Planned sale

Vertex Pharmaceuticals (VRTX): Director filed to sell ~$548K

Thornberry Nancy, Director at Vertex Pharmaceuticals, filed to sell ~$548K of Vertex Pharmaceuticals shares.

~$548K
planned to sell · 1,000 shares, around Nov 16, 2026
Planned for
Nov 16, 2026
Notice filed
Nov 16, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 20, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On October 20, 2026, Daniel Brennan was appointed as a new member of the board of directors (the “Board”) of Vertex Pharmaceuticals Incorporated (the “Company”).”
  2. Nov 2, 2026Company filing · Form 8-K · ResultsReported its results
  3. Nov 6, 2026InsiderCEO sold ~$6.31M of VRTX shares in the open market
  4. Nov 12, 2026Insider · Their largest sale since 2020Officer sold ~$8.37M of VRTX shares in the open market
  5. Nov 13, 20265% stakeCapital Research Global Investors reported a passive stake (13G) of 7.0%
View the official recordSEC Form 144

How to read SEC Form 144

Form 144 is a notice that a company insider plans to sell shares. It is filed when the sell order is placed, so it announces a planned sale and does not prove that the sale took place.

Full guide: What is an SEC Form 144?

What else is on file for Vertex Pharmaceuticals

For Vertex Pharmaceuticals, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its VRTX page.

How this filing works

Explore the data

Common questions

Which Vertex Pharmaceuticals (VRTX) insider traded, and how much?

Thornberry Nancy, Director at Vertex Pharmaceuticals, filed to sell ~$548K of Vertex Pharmaceuticals shares. 1,000 shares, Form 144 notice of a planned sale.

When did it happen, and when was it made public?

Planned for: Nov 16, 2026. Notice filed: Nov 16, 2026.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 144, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Vertex Pharmaceuticals recently?

For Vertex Pharmaceuticals, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the VRTX page.

Does this mean VRTX stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Vertex Pharmaceuticals

Everything OQRO holds on this company is on its VRTX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data